FDA Approved: LOTEMAX SM — Original Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved LOTEMAX SM (loteprednol etabonate) ophthalmic gel under its original application (NDA 208219) from Bausch & Lomb. It is indicated for ocular in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation

Drugs mentioned

• LOTEMAX SM (loteprednol etabonate)

Snippet

ORIG AP for LOTEMAX SM (LOTEPREDNOL ETABONATE)